Search results

Late-stage assessment (LSA) guidance on compression products for treating venous leg ulcers.

Result type

HealthTech guidance

Published

27 August 2025

This manual explains how NICE develops and updates social care guidance. It provides advice on the technical aspects of guidance development and the methods used

Early value assessment (EVA) guidance on virtual ward platform technologies for acute respiratory infections.

Result type

HealthTech guidance

Published

12 October 2023

Evidence-based recommendations on high-intensity focused ultrasound for treating prostate cancer. This involves inserting a probe through the rectum that gives out a beam of ultrasound to heat and destroy the cancerous prostate tissue.

Result type

HealthTech guidance

Published

23 March 2005

Evidence-based recommendations on radium-223 dichloride (Xofigo) for treating hormone-relapsed prostate cancer with bone metastases in adults.

Result type

Technology appraisal guidance

Published

28 September 2016

Evidence-based recommendations on sacubitril valsartan (Entresto) for treating symptomatic chronic heart failure with reduced ejection fraction.

Result type

Technology appraisal guidance

Published

27 April 2016

Evidence-based recommendations on upadacitinib (Rinvoq) for treating moderate active rheumatoid arthritis in adults.

Result type

Technology appraisal guidance

Published

10 November 2021

Evidence-based recommendations on eribulin (Halaven) for locally advanced or metastatic (secondary) breast cancer in adults who have had 2 or more courses of chemotherapy.

Result type

Technology appraisal guidance

Published

21 December 2016

Evidence-based recommendations on atezolizumab (Tecentriq) with bevacizumab (Avastin) for treating advanced or unresectable hepatocellular carcinoma in adults who have not had previous systemic treatment.

Result type

Technology appraisal guidance

Published

16 December 2020

Evidence-based recommendations on entrectinib (Rozlytrek) for ROS1-positive advanced non-small-cell lung cancer (NSCLC) in adults who have not had ROS1 inhibitors.

Result type

Technology appraisal guidance

Published

12 August 2020

Evidence-based recommendations on golimumab (Simponi) for treating psoriatic arthritis in adults.

Result type

Technology appraisal guidance

Published

27 April 2011

Evidence-based recommendations on vemurafenib (Zelboraf) for treating advanced BRAF V600-positive malignant melanoma in adults.

Result type

Technology appraisal guidance

Last updated

1 January 2015

This guideline covers diagnosing and managing constipation in children and young people up to 18. It provides strategies to support the early identification and timely, effective treatment of constipation which will help improve outcomes for patients. It does not cover constipation caused by a specific condition.

Result type

Clinical guideline

Last updated

13 July 2017

Evidence-based recommendations on cytoreduction surgery with hyperthermic intraoperative peritoneal chemotherapy for peritoneal carcinomatosis. This involves surgically removing visible cancer and bathing the abdominal cavity with heated chemotherapy fluid to reach any remaining cancer cells.

Result type

HealthTech guidance

Published

3 March 2021

Evidence-based recommendations on MRI-guided laser interstitial thermal therapy for drug-resistant epilepsy in adults and children. This involves inserting a laser into the area of the brain causing seizures.

Result type

HealthTech guidance

Published

4 March 2020